Healthtech Startups

Valkyrie Industries develops EMS wearable bands (eir) that integrate with VR and mobile apps to support neuromuscular recovery in clinical and fitness settings. The technology enables real-time muscle activation feedback for functional therapy, rehabilitation, and performance training.

1 investor

Valor Vision turns a smartphone into a 3D biomechanics tool that gives athletes a movement profile, injury-risk asymmetry flags, and personalized training plans tracked from baseline through return to play. It serves professional and college sports teams, training facilities, coaches, trainers, and physical therapists for long-term athletic development.

1 investor

Valor Global is a customer experience and contact center outsourcing (BPO) provider that supplies trained support agents, training programs, and quality assurance for clients in sectors such as healthcare and dentistry. It operates across multiple global sites, including a training hub in Costa Rica, offering multichannel customer support, agent onboarding, and performance optimization services.

1 investor

Valorum is a biosimilars company focused on commercializing biosimilar therapies with an emphasis on supply continuity, disciplined pricing, and buy-and-bill partnership models for physician practices, with an initial focus on oncology and ophthalmology. It serves clinicians and specialty care practices in the United States.

1 investor

ValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.

1 investor

ValTech Lifesciences develops next-generation heart valve prostheses using fluid mechanical and cardiovascular engineering research. It provides valve prosthesis manufacturers with patented design features intended to reduce the thrombogenicity of mechanical devices and extend the lifespan of biological devices.

1 investor

Valtruis is a healthcare-focused investment firm that invests in and helps build companies changing how healthcare is accessed, delivered, experienced, and paid for. It provides portfolio companies with access to a network of health system leaders, payor executives, and operators, and is backed by Welsh, Carson, Anderson & Stowe.

1 investor

Vanda is a biopharmaceutical company that develops new medicines, using genetics and genomics to guide drug discovery, clinical trials, and commercial positioning of its compounds. It works to advance novel approaches for delivering these medicines to patients.

1 investor

Vantage Biosciences develops clinical-stage drug therapies for retinal and other diseases, with a focus on the AOC3 target and its role in liver and eye disease. The company works with a network of preclinical and clinical experts to advance therapeutics where existing treatment options are limited.

1 investor

Vantage MedTech provides product development and realization services for medical device and life sciences companies, supporting clients through each stage of bringing MedTech innovations to market. It positions itself as a development partner for healthcare technology firms.

1 investor

Vantari provides VR-based procedural training for healthcare professionals, combining immersive simulation with AI-powered performance analytics and a community platform for medical education.

1 investor

Vantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose

1 investor

Vapogenix is a pharmaceutical developer creating non-opioid pain relief therapies designed for rapid onset and long-lasting effect.

1 investor

Vapore makes Mypurmist, a cordless handheld steam inhaler and air purifier marketed as a drug-free remedy for allergies, sinus congestion, colds, flu and throat and vocal health. The company also offers Mypurskin, a light-therapy skin rejuvenation device, selling consumer respiratory and skincare wellness products to individuals and families.

1 investor

Siemens Healthineers provides integrated technology solutions for cancer care, spanning screening, diagnosis, treatment planning, delivery, and survivorship support. The portfolio aims to coordinate fragmented workflows and simplify clinical decision-making across the cancer care continuum.

1 investor

VascAI provides an AI platform for healthcare care teams that automates clinical workflows including triage, documentation, and patient follow-up through voice agents and treatment co-pilots. The platform is designed to reduce administrative burden, improve patient outcomes, and lower costs for chronic care management.

1 investor

Vascugen develops an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell therapy intended to form new blood vessels and restore microvascular circulation in oxygen-starved tissues. It targets diabetic and arterial disease patients at high risk of limb amputation, and handles development from R&D through cGMP manufacturing.

1 investor

Vave Health develops portable, affordable ultrasound imaging technology aimed at clinicians and healthcare providers, including those serving underserved areas. Its products are used in settings such as medical schools for integrating ultrasound into training.

1 investor

Vaxart is a clinical-stage biotechnology company developing oral recombinant pill vaccines built on its own delivery platform, designed to produce mucosal and systemic immunity against common viral diseases. Its pipeline includes a norovirus vaccine program.

1 investor

VaxCheck is an algorithm-driven clinical decision aid that helps pharmacists identify vaccination gaps and public funding eligibility for adult patients without requiring a prior vaccine record. It is aimed at community pharmacies in Canada, currently supporting pharmacy scope of practice in Ontario with other provinces in development.

1 investor

VAXIMM is a clinical-stage biopharmaceutical company developing oral T-cell immunotherapies for cancer, based on technology invented at UC San Diego. Its lead candidate VXM01 has been evaluated in clinical trials for indications such as pancreatic cancer, and the company operates as a subsidiary of OSR Health.

1 investor

VBA provides a suite of software for administering health benefits, including a core platform for managing multiple lines of business, member web and mobile portals, analytics, APIs, and healthcare data management services. Its solutions serve health plans and benefits administrators, handling functions such as claims auto-adjudication, plan builds, and EDI data transfers.

1 investor

VBI Vaccines is a biopharmaceutical company developing vaccine candidates using virus-like particle (VLP) platforms, including proprietary enveloped VLP and mRNA-launched eVLP technologies. It targets infectious diseases such as hepatitis B, COVID-19, and cytomegalovirus, as well as cancers including glioblastoma.

1 investor

VB Spine develops spinal surgery systems, instrumentation, and surgeon education programs, serving spine surgeons and their patients. It operates in the medical device industry with a product portfolio and clinical resources focused on spine surgery.

1 investor